Inventor
DHAR T G MURALI
US79 patents
⚠️ This page may combine multiple inventors who share the name “DHAR T G MURALI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
35 patentsUS6399773B1Jun 4, 2002
Compounds derived from an amine nucleus that are inhibitors of IMPDH enzyme
BRISTOL MYERS SQUIBB CO105 citations98
US6624184B1Sep 23, 2003
Amide and diamide inhibitors of IMPDH enzyme for use in treating IMPDH-associated disorders
BRISTOL MYERS SQUIBB CO57 citations96
US6916809B2Jul 12, 2005
Heterocyclic acridone inhibitors of IMPDH enzyme
BRISTOL MYERS SQUIBB CO61 citations94
US7205324B2Apr 17, 2007
Inhibitors of IMPDH enzyme
BRISTOL MYERS SQUIBB CO20 citations92
US7060720B2Jun 13, 2006
Inhibitors of IMPDH enzyme
BRISTOL MYERS SQUIBB CO20 citations92
US7053111B2May 30, 2006
Inhibitors of IMPDH enzyme
BRISTOL MYERS SQUIBB CO20 citations92
US6710064B2Mar 23, 2004
Hydantoin compounds useful as anti-inflammatory agents
BRISTOL MYERS SQUIBB CO27 citations91
US9115054B2Aug 25, 2015
Tetrahydronaphthalenyl compounds useful as sipi agonists
BRISTOL MYERS SQUIBB CO13 citations89
US10273259B2Apr 30, 2019
Tricyclic sulfones as RORγ modulators
BRISTOL MYERS SQUIBB CO4 citations84
US6596747B2Jul 22, 2003
Compounds derived from an amine nucleus and pharmaceutical compositions comprising same
BRISTOL MYERS SQUIBB CO20 citations84
US6919335B2Jul 19, 2005
Heterocycles that are inhibitors of IMPDH enzyme
BRISTOL MYERS SQUIBB CO16 citations83
US9815859B2Nov 14, 2017
Tricyclic sulfones as RORγ modulators
BRISTOL MYERS SQUIBB CO11 citations82
US10335392B2Jul 2, 2019
Cyclic compounds useful as modulators of TNF α
BRISTOL MYERS SQUIBB CO5 citations73
US10166249B2Jan 1, 2019
Substituted bicyclic compounds
BRISTOL MYERS SQUIBB CO2 citations73
US9458171B2Oct 4, 2016
Pyrrolidinyl sulfone RORγ modulators
BRISTOL MYERS SQUIBB CO4 citations73
US10035790B2Jul 31, 2018
RORγ modulators
BRISTOL MYERS SQUIBB CO3 citations72
US10023576B2Jul 17, 2018
Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitors
BRISTOL MYERS SQUIBB CO2 citations72
US10435369B2Oct 8, 2019
Tricyclic sulfones as ROR gamma modulators
BRISTOL MYERS SQUIBB CO6 citations71
US7381737B2Jun 3, 2008
Crystalline forms and process for preparing spiro-hydantoin compounds
BRISTOL MYERS SQUIBB CO8 citations71
US11059784B2Jul 13, 2021
Oxime ether compounds
BRISTOL MYERS SQUIBB CO0 citations63
US7943617B2May 17, 2011
Heterobicyclic compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO2 citations63
US7935696B2May 3, 2011
Heterocyclic amide compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO2 citations63
US12570609B2Mar 10, 2026
Tricyclic sulfones as ROR gamma modulators
BRISTOL MYERS SQUIBB CO0 citations62
US11701373B2Jul 18, 2023
Substituted bicyclic compounds
BRISTOL MYERS SQUIBB CO0 citations62
US11058696B2Jul 13, 2021
Substituted bicyclic compounds
BRISTOL MYERS SQUIBB CO0 citations62
US10865191B2Dec 15, 2020
Heterocyclic compounds useful as modulators of TNF alpha
BRISTOL MYERS SQUIBB CO1 citations62
US9522888B2Dec 20, 2016
Substituted bicyclic compounds
BRISTOL MYERS SQUIBB CO2 citations62
US8034940B2Oct 11, 2011
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
BRISTOL MYERS SQUIBB CO4 citations62
US7375237B2May 20, 2008
Pyrrolizine compounds useful as anti-inflammatory agents
BRISTOL MYERS SQUIBB CO4 citations62
US7186727B2Mar 6, 2007
Pyridyl-substituted spiro-hydantoin compounds and use thereof
BRISTOL MYERS SQUIBB CO5 citations62
US7008958B2Mar 7, 2006
2-substituted 5-oxazolyl indole compounds useful as IMPDH inhibitors and pharmaceutical compositions comprising same
BRISTOL MYERS SQUIBB CO4 citations62
US11078186B2Aug 3, 2021
ROR γ modulators
BRISTOL MYERS SQUIBB CO0 citations61
US10968177B2Apr 6, 2021
Tricyclic sulfones as RORγ modulators
BRISTOL MYERS SQUIBB CO0 citations52
US10709719B2Jul 14, 2020
Substituted bicyclic compounds
BRISTOL MYERS SQUIBB CO0 citations52
US10711020B2Jul 14, 2020
Tricyclic sulfones as RORγ modulators
BRISTOL MYERS SQUIBB CO0 citations52
SYNAPTIC PHARMA CORP
8 patentsUS6620815B1Sep 16, 2003
Oxazolidinones and uses thereof
SYNAPTIC PHARMA CORP50 citations96
US6159990ADec 12, 2000
Oxazolidinones as α1A receptor antagonists
SYNAPTIC PHARMA CORP66 citations96
US6268369B1Jul 31, 2001
5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
SYNAPTIC PHARMA CORP28 citations92
US5942517AAug 24, 1999
5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
SYNAPTIC PHARMA CORP28 citations92
US6777426B2Aug 17, 2004
Imidazole and imidazoline derivatives and uses thereof
SYNAPTIC PHARMA CORP4 citations74
US5866579AFeb 2, 1999
Imidazole and imidazoline derivatives and uses thereof
SYNAPTIC PHARMA CORP9 citations74
US6727257B1Apr 27, 2004
5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
SYNAPTIC PHARMA CORP7 citations73
US6248747B1Jun 19, 2001
5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
SYNAPTIC PHARMA CORP4 citations63
CEREP SA
4 patentsUS6977267B2Dec 20, 2005
Spiro-hydantoin compounds useful as anti-inflammatory agents
CEREP SA18 citations90
US7078420B2Jul 18, 2006
Spiro-hydantoin compounds useful as anti-inflammatory agents
CEREP SA7 citations71
US7199125B2Apr 3, 2007
Spiro-cyclic compounds useful as anti-inflammatory agents
CEREP SA5 citations60
US6974815B2Dec 13, 2005
Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
CEREP SA2 citations60
(unassigned)
1 patentDHAR T G MURALI
1 patentGARDNER DANIEL S
1 patentShowing the top 50 of 79 patents by PatentIndex Score.